Search Result "H396P"
Molecular Dynamic Studies Unveil Potential Mechanisms of Resistance to Imatinib in BCR-ABL Mutants
Ebook: Topics in Anti-Cancer Research
Volume: 3 Year: 2014
Author(s): Tai-Sung Lee,Steven J. Potts,Maher Albitar
Doi: 10.2174/9781608059089114030011
Basis for Resistance to Imatinib in 16 BCR-ABL Mutants as Determined Using Molecular Dynamics
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 4 Issue: 2 Year: 2009 Page: 164-173
Author(s): Tai-Sung Lee, Steven J. Potts, Maher Albitar
In Silico Identification and Analysis of Drug Resistant Mutants of ABL Tyrosine Kinase Based on Detrimental Missense Mutations
Journal: Current Signal Transduction Therapy
Volume: 6 Issue: 3 Year: 2011 Page: 396-404
Author(s): R. Rajasekaran, C. George Priya Doss, G. Arun Prasad, Rao Sethumadhavan
New Insights into the Molecular Resistance Mechanisms of Chronic Myeloid Leukemia
Journal: Current Cancer Drug Targets
Volume: 16 Issue: 4 Year: 2016 Page: 323-345
Author(s): Rui Huang,Qian Kang,Huimin Liu,Yuhua Li
New Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia
Journal: Current Pharmaceutical Biotechnology
Volume: 7 Issue: 5 Year: 2006 Page: 371-379
Author(s): Shinya Kimura, Eishi Ashihara, Taira Maekawa
Dual Inhibitors of Src and Abl Tyrosine Kinases
Journal: Drug Design Reviews - Online (Discontinued)
Volume: 1 Issue: 3 Year: 2004 Page: 203-214
Author(s): Diane H. Boschelli
Targeting Protein Multiple Conformations: A Structure-Based Strategy for Kinase Drug Design
Journal: Current Topics in Medicinal Chemistry
Volume: 7 Issue: 1 Year: 2007 Page: 1394-1407
Author(s): Liao Jie-Lou Jeffrey, Andrews C. Robert
Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9 Issue: 8 Year: 2009 Page: 853-863
Author(s): Manlio Tolomeo, Francesco Dieli, Nicola Gebbia, Daniele Simoni
Second Generation Abl Tyrosine Kinase Inhibitors and Novel Compounds to Eliminate the Bcr-Abl/T315I Clone (Second Edition)
Ebook: Frontiers in Anti-Cancer Drug Discovery
Volume: 1 Year: 2010
Author(s): Shinya Kimura
Doi: 10.2174/978160805161811001010116
Second Generation Abl Kinase Inhibitors and Novel Compounds to Eliminate the Bcr-Abl/T315I Clone
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 1 Issue: 3 Year: 2006 Page: 347-355
Author(s): Shinya Kimura